VERVE THERAPEUTICS INC. - COMMON STOCK

Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

05 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 11月 2024 16:26:49 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 10月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 9月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

08 8月 2024 07:00:01 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

28 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

31 5月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Leadership Update

31 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics to Participate in Upcoming Investor Conferences

30 5月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

08 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102

07 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 5月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Updates on its PCSK9 Program

02 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

28 3月 2024 16:51:34 条件 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 3月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

27 2月 2024 07:30:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 2月 2024 06:30:00 条件 Nasdaq GlobeNewswire

Verve Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

02 1月 2024 06:30:11 条件 Nasdaq GlobeNewswire